A phase III trial of medications for castration resistance in metastatic prostate cancer

BH-14-099
Cancer - Prostate, Cancer
Leslie Howard, MD

D’Amour Center for Cancer Care
3350 Main Street
Springfield, MA

Baystate Franklin Medical Center
164 High Street
Greenfield, MA

The purpose of this study is to compare the effects, good and/or bad, of abiraterone, prednisone, and enzalutamide with enzalutamide alone on you and your prostate cancer to find out which is better.
Participants must have progressive castration-resistant metastatic prostate cancer, and rising PSA levels.
Betsy Lopez
413-794-4154